BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12634967)

  • 1. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S; Larisch R; Beu M; Forutan F; Vosberg H; Müller-Gärtner HW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):390-5. PubMed ID: 12634967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.
    Inaji M; Okauchi T; Ando K; Maeda J; Nagai Y; Yoshizaki T; Okano H; Nariai T; Ohno K; Obayashi S; Higuchi M; Suhara T
    Brain Res; 2005 Dec; 1064(1-2):136-45. PubMed ID: 16298352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.
    Nikolaus S; Larisch R; Beu M; Vosberg H; Müller-Gärtner HW
    J Nucl Med; 2001 Nov; 42(11):1691-6. PubMed ID: 11696641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat.
    Mandel RJ; Hartgraves SL; Severson JA; Woodward JJ; Wilcox RE; Randall PK
    Behav Brain Res; 1993 Dec; 59(1-2):53-64. PubMed ID: 8155293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
    Meshul CK; Allen C
    Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.
    Choi JY; Kim CH; Jeon TJ; Cho WG; Lee JS; Lee SJ; Choi TH; Kim BS; Yi CH; Seo Y; Yi DI; Han SJ; Lee M; Kim DG; Lee JD; An G; Ryu YH
    Appl Radiat Isot; 2012 Dec; 70(12):2689-94. PubMed ID: 23041777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive gene expression changes on the healthy side of parkinsonian rats.
    Capper-Loup C; Frey CM; Rebell D; Kaelin-Lang A
    Neuroscience; 2013 Mar; 233():157-65. PubMed ID: 23270858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
    Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
    Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of 6-[
    Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
    J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
    Lawler CP; Gilmore JH; Watts VJ; Walker QD; Southerland SB; Cook LL; Mathis CA; Mailman RB
    Synapse; 1995 Dec; 21(4):299-311. PubMed ID: 8869160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory Bulb D
    Alberts T; Antipova V; Holzmann C; Hawlitschka A; Schmitt O; Kurth J; Stenzel J; Lindner T; Krause BJ; Wree A; Witt M
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
    Casteels C; Lauwers E; Baitar A; Bormans G; Baekelandt V; Van Laere K
    Brain Res; 2010 Feb; 1316():153-62. PubMed ID: 20026090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise protects synaptic density in a rat model of Parkinson's disease.
    Binda KH; Lillethorup TP; Real CC; Bærentzen SL; Nielsen MN; Orlowski D; Brooks DJ; Chacur M; Landau AM
    Exp Neurol; 2021 Aug; 342():113741. PubMed ID: 33965411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
    Atsumi M; Kawakami J; Sugiyama E; Kotaki H; Sawada Y; Sato H; Yamada Y; Iga T
    Synapse; 2003 Nov; 50(2):110-6. PubMed ID: 12923813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
    Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.